pergolide

英式音标：[pɜ:'ɡɒlɪd]

美式音标：[pɜ'ɡɒlɪd]

词汇分类：神经系统（百歌医学单词USMLE）,药理学专业英语词汇,医学英语词汇大集合,医学英语长难词语

词义：

释义

[化] 培高利特，硫丙麦角林；

用法：

双语例句

In this study, use of the dopamine agonists pergolide and cabergoline was associated with an increased risk of newly diagnosed cardiac-valve regurgitation.
研究发现使用多巴胺受体激动剂培高利特和卡麦角林可增加新发生的心脏瓣膜返流的风险。

权威例句

Comparison of pergolide and bromocriptine therapy in parkinsonism

Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.

Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study.

Valvular heart disease in patients taking pergolide.

Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study.

A randomized controlled study of pergolide in patients with restless legs syndrome

Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease

Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome

Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series...

A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease

造句：

1. FDA today is issuing a Public Health Adisory (PHA) detailing the remoal of pergolide products from the market.

FDA今天发布公共健康忠告，详细说明了培高利特撤市的情况。

youdao

2. RESULTS:Pharmacological evaluation showed that Pergolide mesylate is a specific dopminergic DA receptor agonist.

结果：药理评价显示甲磺酸培高利特是一典型D受体激动剂。

youdao

3. The removal of pergolide products is not expected to adversely affect patient care because of the alternative therapies available.

培高利特的撤市希望对患者的治疗不会产生不利的影响，因为有其它的治疗药物可选择。

youdao

4. Objective: Treatment with ergot-derived dopamine agonists, pergolide, and cabergoline has been associated with an increased frequency of valvular heart disease in Parkinson's disease.

目的：使用麦角衍生的多巴胺激动剂，已经证实帕金森病人使用培高利特和卡麦角林可能增加瓣膜心脏病。

youdao

5. "Based on important new drug safety information, FDA has been working with the manufacturers of pergolide products to voluntarily remove these drugs from the market," said Douglas Throckmorton, m.

基于重要的新药安全信息，FDA与培高利特产品的生产厂商决定将其撤市。

youdao

6. "Based on important new drug safety information, FDA has been working with the manufacturers of pergolide products to voluntarily remove these drugs from the market," said Douglas Throckmorton, m.

基于重要的新药安全信息，FDA与培高利特产品的生产厂商决定将其撤市。

youdao